Weiss, Daniel J. http://orcid.org/0000-0002-5515-8062
Segal, Karen
Casaburi, Richard
Hayes, Jack
Tashkin, Donald
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels
https://doi.org/10.1186/s12931-021-01734-8
Funding for this research was provided by:
Mesoblast
Article History
Received: 31 December 2020
Accepted: 26 April 2021
First Online: 8 May 2021
Declarations
:
: The protocol was approved by the institutional review board at each participating center and written informed consent was obtained from each participant.
: Not applicable.
: DJW receives research support from the NIH, Department of Defense, Cystic Fibrosis Foundation, and the University of Vermont. RC is a member of the speaker’s bureau for Glaxo Smith Kline, is a consultant for Genentech, Regeneron and Boehringer Ingelheim and is an advisory board member for Astra Zeneca. His laboratory receives research support from Regeneron, Genentech, Boehringer Ingelheim and Glaxo Smith Kline. KS is a former employee of Mesoblast Inc. and JH is a current employee of Mesoblast Inc. DPT is an advisory board member and speaker for AstraZeneca and Mylan/Theravance. DJW, RC, and DPT had previous research support from Osiris Therapeutics, Inc.